Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03095417 · ClinicalTrials.gov registry record · NA

Improving the Recovery and Outcome Every Day After the ICU

A NA study of Alzheimer Disease and Delirium, sponsored by Indiana University.

Completed
Registry status
NA
Development phase
249
Enrollment target
6
Study locations

NCT03095417 is a NA study of Alzheimer Disease and Delirium that has completed, run by Indiana University. The registered enrollment target is 249 participants, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (91% lower). The trial reports 6 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03095417, a NA study of Alzheimer Disease and Delirium, has completed, sponsored by Indiana University.

COMPLETED
Registry status
NA
Development phase
249 participants
Enrollment target
6
Study locations

Study Summary

Primary Specific Aim: Determine the effect of the combined physical exercise and cognitive training on the cognitive function of ICU survivors aged 50 and older. Hypothesis: In comparison to older ICU survivors randomized to attention control or either intervention alone, those randomized to 12 weeks of combined physical exercise and cognitive training will have higher total index cognitive scores as assessed by the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) at 3 and 6 months post randomization. Secondary Specific Aim 1: Determine the effect of the combined physical exercise and cognitive training on physical performance, anxiety and depressive symptoms, and quality of life of ICU survivors aged 50 and older. Hypotheses: In comparison to older ICU survivors randomized to attention control or either intervention alone, those randomized to 12 weeks of combined physical exercise and cognitive training will have higher physical performance as measured by short physical performance battery (SPPB) and two-minute step test, lower mood and anxiety symptoms as measured by Patient Health Questionnaire (PHQ-9) and Generalized Anxiety Disorder (GAD-7) scale, and higher quality of life as measured by the Medical Outcomes Study 36-item short form (SF-36) at 3 and 6-months post randomization. Exploratory Aim 2: To examine the mechanisms of action of combined training. Hypothesis: At the completion of treatment, the combined intervention group will show reduced serum levels of CRP, IL-1, IL-6, IL-8, TNF-α, S-100β, and GFAP and increased levels of BDNF, VEGF, and IGF-1 compared to the attention control, or either intervention alone groups.

Interventions

  • BEHAVIORAL Cognitive Training Intervention
  • BEHAVIORAL Physical Exercise Intervention
  • BEHAVIORAL Stretching Control
  • BEHAVIORAL Cognitive Control

Study Locations (6)

Indiana

  • Indiana University Health West Hospital - Avon
  • Indiana University Health North Hospital - Carmel
  • Indiana University Health Saxony Hospital - Fishers
  • Eskenazi Health - Indianapolis
  • Indiana University Health Methodist Hospital - Indianapolis
  • Indiana University Health University Hospital - Indianapolis

Trial Details

FieldValue
Enrollment Target 249 participants
Start Date 2017-09-25
Est. Completion 2022-12-15
Phase NA

Sponsor

Indiana University

890 total trials

What the Registry Record Tells You About NCT03095417

The ClinicalTrials.gov registry entry for NCT03095417 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 249 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,750-participant average among 306 other Alzheimer Disease trials with a reported enrollment target (91% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Alzheimer Disease appearing as the primary indexed condition, and to 4 interventions - of which Cognitive Training Intervention is the first listed.

NCT03095417 reports 6 study locations spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT03095417 about?

NCT03095417 is a clinical study titled "Improving the Recovery and Outcome Every Day After the ICU". Primary Specific Aim: Determine the effect of the combined physical exercise and cognitive training on the cognitive function of ICU survivors aged 50 and older. Hypothesis: In comparison to older ICU survivors randomized to attention control or either intervention alone, those randomized to 12 week...

What is the current status of trial NCT03095417?

This trial is currently completed. It is a NA study. The enrollment target is 249 participants. The study started on 2017-09-25. Estimated completion is 2022-12-15.

What conditions does trial NCT03095417 study?

This clinical trial studies the following conditions: Alzheimer Disease, Delirium.

What interventions are being tested in trial NCT03095417?

The interventions under investigation include: Cognitive Training Intervention (BEHAVIORAL), Physical Exercise Intervention (BEHAVIORAL), Stretching Control (BEHAVIORAL), Cognitive Control (BEHAVIORAL).

Who is sponsoring clinical trial NCT03095417?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03095417 being conducted?

This trial has 6 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alzheimer Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.